Description of women at each stage of the IVF treatment process.

<p>Description of women at each stage of the IVF treatment process.</p

Kaplan-Meier curves of time to any second pregnancy following different first pregnancy outcomes.

<p>Kaplan-Meier curves of time to any second pregnancy following different first pregnancy outcomes.</p

Offspring health outcomes comparing planned repeat cesarean with unscheduled repeat cesarean delivery.

<p>Offspring health outcomes comparing planned repeat cesarean with unscheduled repeat cesarean delivery.</p

Demographic characteristics of the planned and unscheduled repeat cesarean groups compared to the VBAC group.

<p>Demographic characteristics of the planned and unscheduled repeat cesarean groups compared to the VBAC group.</p

Cocoa intensification scenarios and their predicted impact on CO2 emissions, biodiversity conservation, and rural livelihoods in the Guinea rain forest of West Africa

The Guinean rain forest (GRF) of West Africa, identified over 20 years ago as a global biodiversity hotspot, had reduced to 113,000 km2 at the start of the new millennium which was 18% of its original area. The principal driver of this environmental change has been the expansion of extensive smallholder agriculture. From 1988 to 2007, the area harvested in the GRF by smallholders of cocoa, cassava, and oil palm increased by 68,000 km2. Field results suggest a high potential for significantly increasing crop yields through increased application of seed-fertilizer technologies. Analyzing land-use change scenarios, it was estimated that had intensified cocoa technology, already developed in the 1960s, been pursued in Cote d’Ivoire, Ghana, Nigeria and Cameroon that over 21,000 km2 of deforestation and forest degradation could have been avoided along with the emission of nearly 1.4 billion t of CO2. Addressing the low productivity of agriculture in the GRF should be one of the principal objectives of REDD climate mitigation programs

CONSORT flow chart for the GaPP1 trial.

<p>DNA = women who did not attend for screening.</p

Cost-effectiveness acceptability curve.

<p>Cost-effectiveness acceptability curve.</p

Adverse events.

<p>Number of participants with at least one adverse event, and severity of the worst event per participant.</p

Exploratory analysis of outcome data.

<p>Exploratory analysis of outcome data.</p

Cost-effectiveness plane.

<p>Cost-effectiveness plane.</p